IntelliEPI Cayman (4971) - Total Liabilities
Based on the latest financial reports, IntelliEPI Cayman (4971) has total liabilities worth NT$206.96 Million TWD (≈ $6.52 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of IntelliEPI Cayman to see how much of total assets are deployed in long-term investments.
IntelliEPI Cayman - Total Liabilities Trend (2011–2025)
This chart illustrates how IntelliEPI Cayman's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see IntelliEPI Cayman assets under control.
IntelliEPI Cayman Competitors by Total Liabilities
The table below lists competitors of IntelliEPI Cayman ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ZENTIVA S.A.
RO:SCD
|
Romania | RON350.60 Million |
|
Afya Ltd
NASDAQ:AFYA
|
USA | $4.78 Billion |
|
Friend Co Ltd
SHG:605050
|
China | CN¥4.13 Billion |
|
Sun Create Electronics Co., Ltd
SHG:600990
|
China | CN¥4.10 Billion |
|
Guangzhou Boji Medical and Biotechnological Co Ltd
SHE:300404
|
China | CN¥569.21 Million |
|
Raisecom Technology Co Ltd
SHG:603803
|
China | CN¥700.26 Million |
|
Shenzhen Textile Holdings Co Ltd
SHE:000045
|
China | CN¥1.17 Billion |
|
Shenzhen Exc Led Technology Co Ltd
SHE:300889
|
China | CN¥1.39 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down IntelliEPI Cayman's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See IntelliEPI Cayman net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IntelliEPI Cayman's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IntelliEPI Cayman (2011–2025)
The table below shows the annual total liabilities of IntelliEPI Cayman from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$127.53 Million ≈ $4.02 Million |
-51.36% |
| 2024-12-31 | NT$262.17 Million ≈ $8.26 Million |
-9.85% |
| 2023-12-31 | NT$290.82 Million ≈ $9.16 Million |
+129.97% |
| 2022-12-31 | NT$126.46 Million ≈ $3.98 Million |
+13.03% |
| 2021-12-31 | NT$111.88 Million ≈ $3.52 Million |
+40.96% |
| 2020-12-31 | NT$79.37 Million ≈ $2.50 Million |
+10.22% |
| 2019-12-31 | NT$72.01 Million ≈ $2.27 Million |
-6.88% |
| 2018-12-31 | NT$77.33 Million ≈ $2.44 Million |
-12.82% |
| 2017-12-31 | NT$88.71 Million ≈ $2.79 Million |
-4.40% |
| 2016-12-31 | NT$92.78 Million ≈ $2.92 Million |
+15.02% |
| 2015-12-31 | NT$80.67 Million ≈ $2.54 Million |
-76.00% |
| 2014-12-31 | NT$336.11 Million ≈ $10.59 Million |
+506.25% |
| 2013-12-31 | NT$55.44 Million ≈ $1.75 Million |
+17.66% |
| 2012-12-31 | NT$47.12 Million ≈ $1.48 Million |
+7.55% |
| 2011-12-31 | NT$43.81 Million ≈ $1.38 Million |
-- |
About IntelliEPI Cayman
IntelliEPI Inc. (Cayman), together with its subsidiaries, produces and sells epitaxy wafers of compound semiconductor for use in wireless communications, data transmission and national defense in the United States, Germany, Korea, Japan, China, and internationally. The company utilizes its proprietary real-time in situ growth monitoring technology on molecular beam epitaxy (MBE) systems for the m… Read more